CLASS II ONGOING Device recall · Reported 1 Nov 2023 · FDA Enforcement Report

CVS PCSU SJH recalled by American Contract Systems

American Contract Systems is recalling CVS PCSU SJH, distributed nationwide in the US. The recall was initiated on 1 Sep 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI/DI 00191072167903, Lot Numbers: 945231, 954231, 974231
Quantity recalled36 cases

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0175-2024
FDA event ID
93086
Recalling firm
American Contract Systems, Temple Terrace, FL
Classification
Class II
Status
Ongoing
Recall initiated
1 Sep 2023
FDA classified
26 Oct 2023
Reported
1 Nov 2023
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Sterility

Timeline

1 Sep 2023Recall initiated by company
26 Oct 2023Classified by FDA+55 days
1 Nov 2023Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

During an internal investigation, ACS identified that the components, I.V. Cath (part number 4252535-02) and Adhesive Dermabond (part number DHVM12) were inadvertently subjected to the ACS sterilization process and exposed to EO and higher temperatures than approved by the component manufacturer. As a result, the components may (1) have a loss/lack of functionality, (2) loss of drug efficacy, if applicable, and (3) have higher than specified EO residuals.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

CVS PCSU SJH, REF SJCV48J

Where it was distributed

US Nationwide distribution in the states of FL, IA.

Nationwide FloridaIowa

Stores named: CVS

Questions about this recall

Why was it recalled?

During an internal investigation, ACS identified that the components, I.V. Cath (part number 4252535-02) and Adhesive Dermabond (part number DHVM12) were inadvertently subjected to the ACS sterilization process and exposed to EO and higher temperatures than approved by the component manufacturer. As a result, the components may (1) have a loss/lack of functionality, (2) loss of drug efficacy, if applicable, and (3) have higher than specified EO residuals.

Which lots are affected?

UDI/DI 00191072167903, Lot Numbers: 945231, 954231, 974231

Where was it sold?

US Nationwide distribution in the states of FL, IA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

11 other products · FDA event 93086

This product is part of a recall event; the main page for the event is Lavh, REF BBLV21C recalled by American Contract Systems.

More recalls from American Contract Systems

All 213

Other Other Medical Devices recalls

All 13,884